Seven Eight Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33,800
| Closed | -$527K | – | 687 |
|
|
2021
Q1 | $527K | Hold |
33,800
| – | – | 0.12% | 256 |
|
|
2020
Q4 | $527K | Buy |
33,800
+7,645
| +29% | +$119K | 0.12% | 259 |
|
|
2020
Q3 | $247K | Buy |
+26,155
| New | +$247K | 0.05% | 484 |
|
|
2019
Q2 | – | Sell |
-47,000
| Closed | -$448K | – | 718 |
|
|
2019
Q1 | $448K | Buy |
+47,000
| New | +$448K | 0.02% | 454 |
|
|
2018
Q2 | – | Sell |
-63,289
| Closed | -$1.2M | – | 568 |
|
|
2018
Q1 | $1.2M | Buy |
63,289
+41,089
| +185% | +$780K | 0.1% | 219 |
|
|
2017
Q4 | $364K | Buy |
+22,200
| New | +$364K | 0.04% | 362 |
|